A multicenter retrospective observational study of effectiveness of mepolizumab in patients with severe eosinophilic asthma and comorbidities in Japan (J-Real-Mepo)
Not Applicable
- Conditions
- Severe asthma
- Registration Number
- JPRN-UMIN000045021
- Lead Sponsor
- Teikyo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) There is a significant lack of information recorded in the medical record. 2) Some or all mepolizumab treatments were performed outside the study site 3) Other than the above, the principal investigator subinvestigator judged the participation in the study to be inappropriate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method